This inventor holds 13 USPTO granted patents, plus 1 CIPO patent. Top assignees: Janssen Pharmaceutica Nv, Ciba-Geigy Corporation. Active years: 1987-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hoogstraten, BE (1987 - 1997)
- Wortel, BE (1997 - 2000)
Company Filing History:

Years Active: 1987-2000
Title: Marcel F De Bruyn: Innovator in Pharmaceutical Compounds
Introduction: Marcel F De Bruyn is a noteworthy inventor based in Hoogstraten, Belgium. With an impressive portfolio of 13 patents, he has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on various derivatives and compounds that hold potential medicinal uses.
Latest Patents: Among his latest patents, De Bruyn has developed derivatives of benzodioxan, benzofuran, and benzopyran. These compounds are characterized by complex chemical formulas that detail bivalent radicals and functional groups, with applications focused on improving fundic relaxation for medical treatments. His work includes vasoconstrictive dihydrobenzopyran derivatives, which also explore formulations and pharmaceutical compositions aimed at various medical uses.
Career Highlights: Throughout his career, Marcel De Bruyn has worked with renowned organizations such as Janssen Pharmaceutica and Ciba-Geigy Corporation. His time at these companies allowed him to refine his research and patenting skills, leading to the development of innovative pharmaceutical solutions that address specific medical conditions.
Collaborations: De Bruyn has collaborated with notable colleagues, including Guy Rosalia Van Lommen and Piet Tom Wigerinck. These professional relationships have enriched his inventiveness and helped advance his research interests in pharmaceuticals and related disciplines.
Conclusion: Marcel F De Bruyn stands out as an influential figure in the realm of pharmaceutical innovations. His extensive patent portfolio reflects his dedication to advancing medical science and his commitment to developing solutions that can improve health outcomes. With continued research and collaboration, De Bruyn is likely to remain a prominent name in pharmaceutical inventions for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile